Elicio Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Elicio Therapeutics, Inc. (ELTX) reported Basic Shares Outstanding (Weighted Average) of 19.24 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- Elicio Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 19.24M shares, a 19.83% increase year-over-year.
- Elicio Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 18.21M shares, a 40.63% increase year-over-year.
- Elicio Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 15.51M shares, a 13.60% increase year-over-year.
- Elicio Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 16.69M shares, a 22.90% increase year-over-year.
- Elicio Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 15.31M shares, a 25.48% increase from fiscal 2024.
- Elicio Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 12.20M shares, a 141.35% increase from fiscal 2023.
- Elicio Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 5.06M shares, a 1500.08% increase from fiscal 2022.
- Elicio Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 316.00K shares, a 98.88% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 19.24M shares 10-Q · filed 2026-08-13 | 18.73M shares 10-Q · filed 2026-08-13 | 17.65M shares derived: average of 3 quarters · filed 2026-08-13 | 17.41M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 18.21M shares 10-Q · filed 2026-05-11 | 16.86M shares derived: average of 2 quarters · filed 2026-05-11 | 16.80M shares derived: average of 3 quarters · filed 2026-05-11 | 16.62M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 15.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 16.10M shares derived: average of 2 quarters · filed 2026-03-12 | 16.09M shares derived: average of 3 quarters · filed 2026-08-13 | 15.31M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 16.69M shares 10-Q · filed 2025-11-13 | 16.38M shares derived: average of 2 quarters · filed 2026-08-13 | 15.25M shares 10-Q · filed 2025-11-13 | 14.84M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 16.06M shares 10-Q · filed 2026-08-13 | 14.51M shares 10-Q · filed 2026-08-13 | 14.22M shares derived: average of 3 quarters · filed 2026-08-13 | 14.06M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 12.95M shares 10-Q · filed 2026-05-11 | 13.30M shares derived: average of 2 quarters · filed 2026-05-11 | 13.39M shares derived: average of 3 quarters · filed 2026-05-11 | 12.87M shares derived: average of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | 13.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 13.62M shares derived: average of 2 quarters · filed 2026-03-12 | 12.84M shares derived: average of 3 quarters · filed 2026-03-12 | 12.20M shares 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | 13.58M shares 10-Q · filed 2025-11-13 | 12.43M shares derived: average of 2 quarters · filed 2025-11-13 | 11.72M shares 10-Q · filed 2025-11-13 | 10.92M shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 11.28M shares 10-Q · filed 2025-08-07 | 10.78M shares 10-Q · filed 2025-08-07 | 10.03M shares derived: average of 3 quarters · filed 2025-08-07 | 9.62M shares derived: average of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | 10.27M shares 10-Q · filed 2025-05-13 | 9.41M shares derived: average of 2 quarters · filed 2025-05-13 | 9.06M shares derived: average of 3 quarters · filed 2025-05-13 | 7.52M shares derived: average of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | 8.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 8.46M shares derived: average of 2 quarters · filed 2025-03-31 | 6.60M shares derived: average of 3 quarters · filed 2025-03-31 | 5.06M shares 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 8.38M shares 10-Q · filed 2024-11-13 | 5.63M shares derived: average of 2 quarters · filed 2024-11-13 | 3.89M shares 10-Q · filed 2024-11-13 | 8.24M shares 10-Q · filed 2023-11-13 | 2.98M shares derived: average of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | 2.89M shares 10-Q · filed 2024-08-13 | 3.10M shares 10-Q · filed 2023-08-14 | 1.62M shares 10-Q · filed 2024-08-13 | 1.72M shares 10-Q · filed 2023-08-14 | 1.18M shares derived: average of 3 quarters · filed 2024-08-13 | 963.75K shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 324.11K shares 10-Q · filed 2024-05-15 | 30.11M shares 10-Q · filed 2023-05-10 | 322.12K shares derived: average of 2 quarters · filed 2024-05-15 | 320.58K shares derived: average of 3 quarters · filed 2024-05-15 | 319.08K shares derived: average of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | 320.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 318.82K shares derived: average of 2 quarters · filed 2024-03-29 | 317.41K shares derived: average of 3 quarters · filed 2024-03-29 | 316.00K shares 10-K · filed 2024-03-29 | 30.04M shares 10-K · filed 2023-03-17 | |||
| 2022-09-30 | 317.51K shares 10-Q · filed 2023-11-13 | 30.11M shares 10-Q · filed 2022-11-14 | 316.04K shares derived: average of 2 quarters · filed 2023-11-13 | 314.62K shares 10-Q · filed 2023-11-13 | 30.02M shares 10-Q · filed 2022-11-14 | 15.14M shares derived: average of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | 314.57K shares 10-Q · filed 2023-08-14 | 29.97M shares 10-Q · filed 2022-08-15 | 313.15K shares 10-Q · filed 2023-08-14 | 29.97M shares 10-Q · filed 2022-08-15 | 20.08M shares derived: average of 3 quarters · filed 2023-08-14 | 22.52M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 29.96M shares 10-Q · filed 2023-05-10 | 29.96M shares derived: average of 2 quarters · filed 2023-05-10 | 29.92M shares derived: average of 3 quarters · filed 2023-05-10 | 29.86M shares derived: average of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | 29.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | 29.90M shares derived: average of 2 quarters · filed 2023-03-17 | 29.82M shares derived: average of 3 quarters · filed 2023-03-17 | 28.24M shares 10-K · filed 2023-03-17 | ||||
| 2021-09-30 | 29.83M shares 10-Q · filed 2022-11-14 | 29.75M shares derived: average of 2 quarters · filed 2022-11-14 | 27.67M shares 10-Q · filed 2022-11-14 | 24.54M shares derived: average of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | 29.67M shares 10-Q · filed 2022-08-15 | 26.57M shares 10-Q · filed 2022-08-15 | 22.78M shares derived: average of 3 quarters · filed 2022-08-15 | 20.80M shares derived: average of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | 23.44M shares 10-Q · filed 2022-05-16 | 19.33M shares derived: average of 2 quarters · filed 2022-05-16 | 17.84M shares derived: average of 3 quarters · filed 2022-05-16 | 17.01M shares derived: average of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | 15.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 15.03M shares derived: average of 2 quarters · filed 2022-03-30 | 14.86M shares derived: average of 3 quarters · filed 2022-03-30 | 14.76M shares 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | 14.85M shares 10-Q · filed 2021-11-12 | 14.68M shares derived: average of 2 quarters · filed 2021-11-12 | 14.61M shares 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | 14.51M shares 10-Q · filed 2021-08-12 | 14.49M shares 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | 14.46M shares 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |